{"disease":{"id":"carcinoma-basal-cell","name":"carcinoma basal cell"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04969419","title":"Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo","phase":"","overall_status":"COMPLETED","enrollment_count":75771,"lead_sponsor_name":"Momentum Data","has_results":true},{"nct_id":"NCT03210935","title":"French National Database of Rare Dermatological Cancers","phase":"","overall_status":"UNKNOWN","enrollment_count":9000,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT02310503","title":"Spanish Registry of Mohs Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":6000,"lead_sponsor_name":"Fundación Academia Española de Dermatología","has_results":false},{"nct_id":"NCT03509467","title":"Using MC1R Genotype to Impact Melanoma Risk Behavior","phase":"NA","overall_status":"COMPLETED","enrollment_count":2054,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":true},{"nct_id":"NCT03050268","title":"Familial Investigations of Childhood Cancer Predisposition","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT06536257","title":"Personalised Immunotherapy Platform","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Melanoma Institute Australia","has_results":false},{"nct_id":"NCT00847912","title":"CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":954,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT02834013","title":"Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":818,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05078047","title":"Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":646,"lead_sponsor_name":"UNICANCER","has_results":false},{"nct_id":"NCT03482622","title":"Intraoperative Detection of Residual BCC by Fast Raman","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT03092830","title":"Molecular Characterization of Cutaneous Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Rabin Medical Center","has_results":false},{"nct_id":"NCT07361666","title":"Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji","has_results":false},{"nct_id":"NCT06227416","title":"Skin Tumor Biomarkers by Mass Spectrometry Imaging","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT07501780","title":"Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":297,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT07384078","title":"High Intensity Focused Ultrasound vs. Cryotherapy in the Treatment of Basal Cell Carcinomas and Bowen's Disease in Adults","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":294,"lead_sponsor_name":"Jussi Salonen","has_results":false},{"nct_id":"NCT02623101","title":"Reflectance Confocal Microscopy in Basal Cell Carcinoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":288,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT03836105","title":"CemiplimAb Survivorship Epidemiology","phase":"","overall_status":"COMPLETED","enrollment_count":287,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT05969860","title":"At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03237013","title":"Strategies to Promote Skin Health","phase":"NA","overall_status":"COMPLETED","enrollment_count":219,"lead_sponsor_name":"San Diego State University","has_results":true},{"nct_id":"NCT04389112","title":"Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06880848","title":"Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT03822988","title":"ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT03517488","title":"A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Xencor, Inc.","has_results":false},{"nct_id":"NCT03132636","title":"PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":138,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT05086692","title":"A Beta-only IL-2 ImmunoTherapY Study","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":115,"lead_sponsor_name":"Medicenna Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04272034","title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":105,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT04695015","title":"Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT03889912","title":"Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT05188729","title":"Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Verrica Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT03420846","title":"Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping","phase":"NA","overall_status":"TERMINATED","enrollment_count":86,"lead_sponsor_name":"Michelson Diagnostics Ltd.","has_results":false},{"nct_id":"NCT04916002","title":"A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":77,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT05929664","title":"Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT07215988","title":"Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a \"Filter\" Observational Study","phase":"","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT02978625","title":"Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":68,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02674009","title":"Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT07455331","title":"Flash Radiotherapy for Skin Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Jules Bordet Institute","has_results":false},{"nct_id":"NCT05859074","title":"A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT03370861","title":"How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes","phase":"","overall_status":"TERMINATED","enrollment_count":54,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04744935","title":"Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Christopher Zachary","has_results":false},{"nct_id":"NCT05133427","title":"HIFU for Treatment of Non-nodular and Recurrent BCC","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Joergen Serup","has_results":false},{"nct_id":"NCT07144384","title":"Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Kirsten Johnson","has_results":false},{"nct_id":"NCT03467789","title":"Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT03799445","title":"Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":37,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT05138328","title":"Laser Treatment of Basal Cell Carcinoma Under Imaging Guidance","phase":"NA","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Henry Ford Health System","has_results":false},{"nct_id":"NCT04124796","title":"Identification of Psychosocial Factors Associated With Diagnostic Delay in Advanced Basal Cell Carcinoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT03610022","title":"Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT04470726","title":"Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"AiViva BioPharma, Inc.","has_results":false},{"nct_id":"NCT05797415","title":"Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers","phase":"","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03897036","title":"Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Senhwa Biosciences, Inc.","has_results":true},{"nct_id":"NCT03208296","title":"Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)","phase":"PHASE1, PHASE2","overall_status":"SUSPENDED","enrollment_count":24,"lead_sponsor_name":"Ascend Biopharmaceuticals Ltd","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}